Trial Profile
Effectiveness of Pramlintide on Control of Post-Transplant Diabetes Mellitus.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I/II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Pramlintide (Primary) ; Antihyperglycaemics; Insulin
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 02 Aug 2010 New trial record